US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 4.520
  • +0.260+6.10%
Close Nov 25 16:00 ET
  • 4.520
  • 0.0000.00%
Post 16:02 ET
241.24MMarket Cap-4757P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-448.24%-27.92M
-19.09%-26.23M
-24.08%-29.27M
7.74%-61.36M
-48.44%-23.77M
147.15%8.02M
-64.75%-22.02M
-17.21%-23.59M
-36.62%-66.5M
-11.34%-16.01M
Net income from continuing operations
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-34.73%-89.22M
-4.75%-19.61M
-41.56%-23M
-59.27%-24.05M
-39.66%-22.56M
-36.19%-66.22M
-31.85%-18.72M
Depreciation and amortization
-20.14%1.03M
-13.89%1.12M
-16.34%1.25M
4.36%5.36M
-13.75%1.28M
2.80%1.29M
7.37%1.3M
25.44%1.5M
54.36%5.14M
29.95%1.48M
Other non cash items
-10.76%199K
-7.34%202K
-7.01%199K
191.15%757K
-52.78%102K
--223K
--218K
--214K
--260K
--216K
Change In working capital
-100.98%-279K
407.03%2.18M
45.70%-2.11M
272.10%17.61M
-2,082.39%-6.2M
961.10%28.4M
-41.92%-711K
36.81%-3.88M
-73.51%-10.23M
86.51%-284K
-Change in prepaid assets
-68.88%-1.17M
-100.52%-15K
121.61%255K
340.24%985K
-102.46%-49K
53.86%-694K
140.33%2.91M
43.97%-1.18M
84.20%-410K
350.23%1.99M
-Change in payables and accrued expense
107.21%1.55M
103.57%2.34M
-263.31%-2.01M
201.67%3.8M
-61.43%670K
56.69%749K
13.08%1.15M
162.47%1.23M
-61.16%1.26M
382.44%1.74M
-Change in other working capital
81.60%-659K
-100.53%-143K
91.06%-352K
215.70%12.82M
-70.01%-6.82M
-57.66%-3.58M
1,095.49%27.16M
-90.24%-3.94M
-69.29%-11.08M
-107.50%-4.01M
Cash from discontinued investing activities
Operating cash flow
-448.24%-27.92M
-19.09%-26.23M
-24.08%-29.27M
7.74%-61.36M
-48.44%-23.77M
147.15%8.02M
-64.75%-22.02M
-17.21%-23.59M
-36.62%-66.5M
-11.34%-16.01M
Investing cash flow
Cash flow from continuing investing activities
-34.09%-82.35M
-7,927.62%-33.72M
4,415.39%36.16M
-1,338.08%-60.76M
238.93%1.91M
-14,384.43%-61.41M
77.81%-420K
-57.82%-838K
57.50%-4.23M
37.72%-1.38M
Net PPE purchase and sale
3.45%-1.37M
-105.24%-862K
15.87%-705K
25.54%-3.15M
65.94%-469K
-234.67%-1.42M
77.81%-420K
-57.82%-838K
57.50%-4.23M
37.72%-1.38M
Net investment purchase and sale
-34.98%-80.98M
---32.85M
--36.87M
---57.61M
--2.38M
---60M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-34.09%-82.35M
-7,927.62%-33.72M
4,415.39%36.16M
-1,338.08%-60.76M
238.93%1.91M
-14,384.43%-61.41M
77.81%-420K
-57.82%-838K
57.50%-4.23M
37.72%-1.38M
Financing cash flow
Cash flow from continuing financing activities
588.10%1.23M
19.10%161.59M
258K
361.38%135.44M
-82.41%19K
-100.87%-252K
437,564.52%135.68M
0
-84.52%29.36M
-10.00%108K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--29.35M
--0
Net common stock issuance
--0
----
----
21,876.17%42.41M
--0
---186K
----
----
-99.78%193K
--193K
Proceeds from stock option exercised by employees
1,963.64%1.23M
38.01%128.46M
--258K
69,846.62%93.03M
111.11%19K
-1,420.00%-66K
300,145.16%93.08M
--0
-54.30%133K
-92.50%9K
Net other financing activities
----
----
----
----
----
----
----
----
---324K
---94K
Cash from discontinued financing activities
Financing cash flow
588.10%1.23M
19.10%161.59M
--258K
361.38%135.44M
-82.41%19K
-100.87%-252K
437,564.52%135.68M
--0
-84.52%29.36M
-10.00%108K
Net cash flow
Beginning cash position
15.58%247.19M
44.62%145.54M
10.66%138.39M
-24.86%125.06M
12.56%160.22M
63.71%213.87M
-31.01%100.64M
-24.86%125.06M
370.34%166.44M
-22.18%142.34M
Current changes in cash
-103.25%-109.04M
-10.23%101.65M
129.29%7.15M
132.21%13.33M
-26.36%-21.83M
-558.42%-53.65M
843.54%113.23M
-18.76%-24.43M
-131.57%-41.37M
-4.91%-17.28M
End cash Position
-13.78%138.15M
15.58%247.19M
44.62%145.54M
10.66%138.39M
10.66%138.39M
12.56%160.22M
63.71%213.87M
-31.01%100.64M
-24.86%125.06M
-24.86%125.06M
Free cash flow
-543.89%-29.29M
-20.70%-27.09M
-22.71%-29.97M
8.80%-64.5M
-39.39%-24.24M
137.86%6.6M
-47.06%-22.44M
-18.25%-24.43M
-20.66%-70.73M
-4.80%-17.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -448.24%-27.92M-19.09%-26.23M-24.08%-29.27M7.74%-61.36M-48.44%-23.77M147.15%8.02M-64.75%-22.02M-17.21%-23.59M-36.62%-66.5M-11.34%-16.01M
Net income from continuing operations -29.96%-29.89M-31.67%-31.66M-33.59%-30.14M-34.73%-89.22M-4.75%-19.61M-41.56%-23M-59.27%-24.05M-39.66%-22.56M-36.19%-66.22M-31.85%-18.72M
Depreciation and amortization -20.14%1.03M-13.89%1.12M-16.34%1.25M4.36%5.36M-13.75%1.28M2.80%1.29M7.37%1.3M25.44%1.5M54.36%5.14M29.95%1.48M
Other non cash items -10.76%199K-7.34%202K-7.01%199K191.15%757K-52.78%102K--223K--218K--214K--260K--216K
Change In working capital -100.98%-279K407.03%2.18M45.70%-2.11M272.10%17.61M-2,082.39%-6.2M961.10%28.4M-41.92%-711K36.81%-3.88M-73.51%-10.23M86.51%-284K
-Change in prepaid assets -68.88%-1.17M-100.52%-15K121.61%255K340.24%985K-102.46%-49K53.86%-694K140.33%2.91M43.97%-1.18M84.20%-410K350.23%1.99M
-Change in payables and accrued expense 107.21%1.55M103.57%2.34M-263.31%-2.01M201.67%3.8M-61.43%670K56.69%749K13.08%1.15M162.47%1.23M-61.16%1.26M382.44%1.74M
-Change in other working capital 81.60%-659K-100.53%-143K91.06%-352K215.70%12.82M-70.01%-6.82M-57.66%-3.58M1,095.49%27.16M-90.24%-3.94M-69.29%-11.08M-107.50%-4.01M
Cash from discontinued investing activities
Operating cash flow -448.24%-27.92M-19.09%-26.23M-24.08%-29.27M7.74%-61.36M-48.44%-23.77M147.15%8.02M-64.75%-22.02M-17.21%-23.59M-36.62%-66.5M-11.34%-16.01M
Investing cash flow
Cash flow from continuing investing activities -34.09%-82.35M-7,927.62%-33.72M4,415.39%36.16M-1,338.08%-60.76M238.93%1.91M-14,384.43%-61.41M77.81%-420K-57.82%-838K57.50%-4.23M37.72%-1.38M
Net PPE purchase and sale 3.45%-1.37M-105.24%-862K15.87%-705K25.54%-3.15M65.94%-469K-234.67%-1.42M77.81%-420K-57.82%-838K57.50%-4.23M37.72%-1.38M
Net investment purchase and sale -34.98%-80.98M---32.85M--36.87M---57.61M--2.38M---60M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow -34.09%-82.35M-7,927.62%-33.72M4,415.39%36.16M-1,338.08%-60.76M238.93%1.91M-14,384.43%-61.41M77.81%-420K-57.82%-838K57.50%-4.23M37.72%-1.38M
Financing cash flow
Cash flow from continuing financing activities 588.10%1.23M19.10%161.59M258K361.38%135.44M-82.41%19K-100.87%-252K437,564.52%135.68M0-84.52%29.36M-10.00%108K
Net issuance payments of debt --------------0------------------29.35M--0
Net common stock issuance --0--------21,876.17%42.41M--0---186K---------99.78%193K--193K
Proceeds from stock option exercised by employees 1,963.64%1.23M38.01%128.46M--258K69,846.62%93.03M111.11%19K-1,420.00%-66K300,145.16%93.08M--0-54.30%133K-92.50%9K
Net other financing activities -----------------------------------324K---94K
Cash from discontinued financing activities
Financing cash flow 588.10%1.23M19.10%161.59M--258K361.38%135.44M-82.41%19K-100.87%-252K437,564.52%135.68M--0-84.52%29.36M-10.00%108K
Net cash flow
Beginning cash position 15.58%247.19M44.62%145.54M10.66%138.39M-24.86%125.06M12.56%160.22M63.71%213.87M-31.01%100.64M-24.86%125.06M370.34%166.44M-22.18%142.34M
Current changes in cash -103.25%-109.04M-10.23%101.65M129.29%7.15M132.21%13.33M-26.36%-21.83M-558.42%-53.65M843.54%113.23M-18.76%-24.43M-131.57%-41.37M-4.91%-17.28M
End cash Position -13.78%138.15M15.58%247.19M44.62%145.54M10.66%138.39M10.66%138.39M12.56%160.22M63.71%213.87M-31.01%100.64M-24.86%125.06M-24.86%125.06M
Free cash flow -543.89%-29.29M-20.70%-27.09M-22.71%-29.97M8.80%-64.5M-39.39%-24.24M137.86%6.6M-47.06%-22.44M-18.25%-24.43M-20.66%-70.73M-4.80%-17.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data